Skip to main content

COVID-19 Topic Center

Schizophrenia News

News
Although adding pimavanserin to antipsychotic treatment in adults with schizophrenia showed a consistent trend in improvement of symptoms, results from a phase 3 study did not achieve statistical significance on the trial’s primary endpoint, Acadia Pharmaceuticals announced. “Unfortunately, we did…
News
By Will Boggs MD NEW YORK—Most oral antipsychotics are effective for acute treatment of multi-episode schizophrenia in adults, but it's not clear which, if any, is best, according to a new network meta-analysis comparing 32 drugs. "All antipsychotics have their individual advantages and…
News
Cognitive decline continues for years after the onset of schizophrenia and other psychoses, although it varies across cognitive functions and diagnoses, according to a study published online in The American Journal of Psychiatry. “Schizophrenia is associated with a marked cognitive impairment that…
News
By Reuters Staff NEW YORK—Nicotine restores dynamic intrinsic brain activity in the left dorsolateral prefrontal cortex (DLPFC) of people with schizophrenia, researchers from China have found. Schizophrenia-nicotine-dependence comorbidity is "complicated and multifactorial," Dr. Siqi Yang of the…
News
By Will Boggs MD NEW YORK—People with schizophrenia have a different pattern of electrocardiogram (ECG) abnormalities than do controls, and those taking antipsychotics have more such abnormalities than do patients not on the drugs, according to a nationally representative study from Denmark. "The…
News
By Anne Harding NEW YORK—A smoking-cessation program tailored to people with schizophrenia and bipolar disorder may help some quit, new findings show. "It doesn't disrupt their mental health. In fact we know from research that the opposite is true. Quitting smoking is really good for your mental…
Back to Top